Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE-HBOT
NCT05980195Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2024
- Primary completion
- Dec 2025
01
Overview
Randomised, open-label trial (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Montreal Cognitive Assessment at 6 months. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05980195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05980195.